KSA aims to be regional hub for biomedical technology
High-profile forum in Riyadh brings global experts together to develop the Kingdom’s health sector
Saudi Arabia is working with global leaders in the field to become a regional hub for biomedical technology, delegates to a high-profile forum in Riyadh heard on Tuesday.
The Riyadh Global Medical Biotechnology Summit was “a unique, interactive and dynamic gathering from local and international key players to make Saudi Arabia the gateway to thriving biotechnology,” said Dr. Ahmed Alaskar, the event’s chairman and director of the King Abdullah International
Medical Research Center.
Dr. Bandar Al-Knawy, chief executive of health affairs at the Ministry of National Guard, said the three-day event aimed to develop the Saudi health sector and promote investment in biomedical technology.
He said the forum was of great importance because of the challenges the world faced in developing vaccines, and the impact medical technology could have on the future of health, industry and investment.
Al-Knawy said experts and leaders in the health sector from
Agreements are expected to be signed between Saudi ministries and pharmaceutical giants to produce COVID-19 vaccines in the Kingdom. around the world would present opportunities and shed light on strategies for optimal investment in medical technology and its role in developing vaccines, as well as and cellular and genetic treatments.
Agreements are expected to be signed at the event between Saudi government ministries and pharmaceutical giants including AstraZeneca and Pfizer to produce COVID-19 vaccines in the Kingdom.
“We believe Saudi Arabia will be a regional hub for manufacturing biomedical products,” said Suliman Al-Mazroua, chief executive of the National Industrial Development and Logistics Program.